Schizophrenia: Rewriting the Story of a Misunderstood Illness

Schizophrenia affects about 1% of the global population. It typically begins in late adolescence or early adulthood and presents with positive symptoms (hallucinations, delusions), negative symptoms (social withdrawal, blunted affect, avolition) and cognitive difficulties. The single most important predictor of long-term outcome is the duration of untreated psychosis. The earlier antipsychotic medication, psychosocial support and family education begin, the better the prognosis. Modern second-generation antipsychotics have transformed treatment — and with regular follow-up, many patients live full, productive, married, employed lives. At Manas, we focus on three things in schizophrenia care: (1) consistent medication using the lowest effective dose and long-acting injectables when adherence is an issue, (2) family psychoeducation so that loved ones become allies in care, (3) vocational and social rehabilitation so the illness does not become an identity. The old narrative around schizophrenia is wrong. With timely, dignified treatment, this is a manageable illness — not a sentence.